SSA
GH icon

Schonfeld Strategic Advisors’s Guardant Health GH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$308K – 2753
2022
Q3 		$308K Buy
+50,000
New +$2.57M ﹤0.01% 2063

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's GH Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its Guardant Health (GH) stake by 1,311% in Q1 2026, buying an estimated $6.69M and bringing the position to 71,684 shares worth $6.62M. The position accounts for 0.05% of the portfolio, ranked #412.

Schonfeld Strategic Advisors first reported a position in GH in Q4 2018 and has held it in 17 quarters since. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Schonfeld Strategic Advisors held 71,684 shares of Guardant Health worth $6.62M as of Q1 2026.
  • Schonfeld Strategic Advisors bought 66,603 Guardant Health shares in Q1 2026, an estimated $6.69M.
  • Guardant Health made up 0.05% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #412 holding.
  • Schonfeld Strategic Advisors first reported a position in Guardant Health in Q4 2018 and has held it in 17 quarters since.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.